Medical Care
Global Radiopharmaceutical Non-clinical CRO Service Market Research Report 2025
- Jun 25, 25
- ID: 337883
- Pages: 88
- Figures: 85
- Views: 3
The global market for Radiopharmaceutical Non-clinical CRO Service was valued at US$ 1565 million in the year 2024 and is projected to reach a revised size of US$ 4581 million by 2031, growing at a CAGR of 16.6% during the forecast period.
Radiopharmaceutical non-clinical CRO services refer to systematic research services including pharmacodynamics, safety, pharmacokinetics, and imaging verification provided by professional contract research organizations to pharmaceutical companies or scientific research institutions in the early stages of radiopharmaceutical research and development. This service covers key links from target verification, animal model establishment, radiolabeling, image acquisition and analysis to dose estimation, and is widely used in tumor, central nervous system, cardiovascular and other disease fields, helping the preclinical evaluation and new drug application of radiopharmaceuticals and accelerating their clinical transformation process.
North American market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Radiopharmaceutical Non-clinical CRO Service in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Radiopharmaceutical Non-clinical CRO Service include Charles River, Novotech, Oncodesign Services, Aixial, ABX - CRO, CMIC, Medpace, Minerva Imaging, Chelatec, Konica Minolta, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Non-clinical CRO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Non-clinical CRO Service.
The Radiopharmaceutical Non-clinical CRO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceutical Non-clinical CRO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, by Disease and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical Non-clinical CRO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Novotech
Oncodesign Services
Aixial
ABX - CRO
CMIC
Medpace
Minerva Imaging
Chelatec
Konica Minolta
MITRO Biotech
C-Ray
InnoStar Bio-tech
Segment by Type
Tracers
Therapeutic Radiopharmaceuticals
Segment by Disease
Tumor Diseases
Nervous System Diseases
Cardiovascular Diseases
Other
Segment by Application
Pharmaceutical Companies
Biotech Companies
Government Agencies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Disease etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical Non-clinical CRO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Radiopharmaceutical non-clinical CRO services refer to systematic research services including pharmacodynamics, safety, pharmacokinetics, and imaging verification provided by professional contract research organizations to pharmaceutical companies or scientific research institutions in the early stages of radiopharmaceutical research and development. This service covers key links from target verification, animal model establishment, radiolabeling, image acquisition and analysis to dose estimation, and is widely used in tumor, central nervous system, cardiovascular and other disease fields, helping the preclinical evaluation and new drug application of radiopharmaceuticals and accelerating their clinical transformation process.
North American market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Radiopharmaceutical Non-clinical CRO Service in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Radiopharmaceutical Non-clinical CRO Service include Charles River, Novotech, Oncodesign Services, Aixial, ABX - CRO, CMIC, Medpace, Minerva Imaging, Chelatec, Konica Minolta, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Non-clinical CRO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Non-clinical CRO Service.
The Radiopharmaceutical Non-clinical CRO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceutical Non-clinical CRO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, by Disease and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical Non-clinical CRO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Novotech
Oncodesign Services
Aixial
ABX - CRO
CMIC
Medpace
Minerva Imaging
Chelatec
Konica Minolta
MITRO Biotech
C-Ray
InnoStar Bio-tech
Segment by Type
Tracers
Therapeutic Radiopharmaceuticals
Segment by Disease
Tumor Diseases
Nervous System Diseases
Cardiovascular Diseases
Other
Segment by Application
Pharmaceutical Companies
Biotech Companies
Government Agencies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Disease etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical Non-clinical CRO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tracers
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Market by Disease
1.3.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031
1.3.2 Tumor Diseases
1.3.3 Nervous System Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Market by Application
1.4.1 Global Radiopharmaceutical Non-clinical CRO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Pharmaceutical Companies
1.4.3 Biotech Companies
1.4.4 Government Agencies
1.4.5 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Perspective (2020-2031)
2.2 Global Radiopharmaceutical Non-clinical CRO Service Growth Trends by Region
2.2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Region (2020-2025)
2.2.3 Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Region (2026-2031)
2.3 Radiopharmaceutical Non-clinical CRO Service Market Dynamics
2.3.1 Radiopharmaceutical Non-clinical CRO Service Industry Trends
2.3.2 Radiopharmaceutical Non-clinical CRO Service Market Drivers
2.3.3 Radiopharmaceutical Non-clinical CRO Service Market Challenges
2.3.4 Radiopharmaceutical Non-clinical CRO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Revenue
3.1.1 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Revenue (2020-2025)
3.1.2 Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiopharmaceutical Non-clinical CRO Service Revenue
3.4 Global Radiopharmaceutical Non-clinical CRO Service Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Non-clinical CRO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Non-clinical CRO Service Revenue in 2024
3.5 Global Key Players of Radiopharmaceutical Non-clinical CRO Service Head office and Area Served
3.6 Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Product and Application
3.7 Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Non-clinical CRO Service Breakdown Data by Type
4.1 Global Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Type (2020-2025)
4.2 Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Type (2026-2031)
5 Radiopharmaceutical Non-clinical CRO Service Breakdown Data by Application
5.1 Global Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Application (2020-2025)
5.2 Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
6.2 North America Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
6.4 North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
7.2 Europe Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
7.4 Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
8.2 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
9.2 Latin America Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
9.4 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
10.2 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiopharmaceutical Non-clinical CRO Service Introduction
11.1.4 Charles River Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Novotech
11.2.1 Novotech Company Details
11.2.2 Novotech Business Overview
11.2.3 Novotech Radiopharmaceutical Non-clinical CRO Service Introduction
11.2.4 Novotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.2.5 Novotech Recent Development
11.3 Oncodesign Services
11.3.1 Oncodesign Services Company Details
11.3.2 Oncodesign Services Business Overview
11.3.3 Oncodesign Services Radiopharmaceutical Non-clinical CRO Service Introduction
11.3.4 Oncodesign Services Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.3.5 Oncodesign Services Recent Development
11.4 Aixial
11.4.1 Aixial Company Details
11.4.2 Aixial Business Overview
11.4.3 Aixial Radiopharmaceutical Non-clinical CRO Service Introduction
11.4.4 Aixial Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.4.5 Aixial Recent Development
11.5 ABX - CRO
11.5.1 ABX - CRO Company Details
11.5.2 ABX - CRO Business Overview
11.5.3 ABX - CRO Radiopharmaceutical Non-clinical CRO Service Introduction
11.5.4 ABX - CRO Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.5.5 ABX - CRO Recent Development
11.6 CMIC
11.6.1 CMIC Company Details
11.6.2 CMIC Business Overview
11.6.3 CMIC Radiopharmaceutical Non-clinical CRO Service Introduction
11.6.4 CMIC Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.6.5 CMIC Recent Development
11.7 Medpace
11.7.1 Medpace Company Details
11.7.2 Medpace Business Overview
11.7.3 Medpace Radiopharmaceutical Non-clinical CRO Service Introduction
11.7.4 Medpace Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.7.5 Medpace Recent Development
11.8 Minerva Imaging
11.8.1 Minerva Imaging Company Details
11.8.2 Minerva Imaging Business Overview
11.8.3 Minerva Imaging Radiopharmaceutical Non-clinical CRO Service Introduction
11.8.4 Minerva Imaging Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.8.5 Minerva Imaging Recent Development
11.9 Chelatec
11.9.1 Chelatec Company Details
11.9.2 Chelatec Business Overview
11.9.3 Chelatec Radiopharmaceutical Non-clinical CRO Service Introduction
11.9.4 Chelatec Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.9.5 Chelatec Recent Development
11.10 Konica Minolta
11.10.1 Konica Minolta Company Details
11.10.2 Konica Minolta Business Overview
11.10.3 Konica Minolta Radiopharmaceutical Non-clinical CRO Service Introduction
11.10.4 Konica Minolta Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.10.5 Konica Minolta Recent Development
11.11 MITRO Biotech
11.11.1 MITRO Biotech Company Details
11.11.2 MITRO Biotech Business Overview
11.11.3 MITRO Biotech Radiopharmaceutical Non-clinical CRO Service Introduction
11.11.4 MITRO Biotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.11.5 MITRO Biotech Recent Development
11.12 C-Ray
11.12.1 C-Ray Company Details
11.12.2 C-Ray Business Overview
11.12.3 C-Ray Radiopharmaceutical Non-clinical CRO Service Introduction
11.12.4 C-Ray Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.12.5 C-Ray Recent Development
11.13 InnoStar Bio-tech
11.13.1 InnoStar Bio-tech Company Details
11.13.2 InnoStar Bio-tech Business Overview
11.13.3 InnoStar Bio-tech Radiopharmaceutical Non-clinical CRO Service Introduction
11.13.4 InnoStar Bio-tech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.13.5 InnoStar Bio-tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tracers
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Market by Disease
1.3.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031
1.3.2 Tumor Diseases
1.3.3 Nervous System Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Market by Application
1.4.1 Global Radiopharmaceutical Non-clinical CRO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Pharmaceutical Companies
1.4.3 Biotech Companies
1.4.4 Government Agencies
1.4.5 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Perspective (2020-2031)
2.2 Global Radiopharmaceutical Non-clinical CRO Service Growth Trends by Region
2.2.1 Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Region (2020-2025)
2.2.3 Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Region (2026-2031)
2.3 Radiopharmaceutical Non-clinical CRO Service Market Dynamics
2.3.1 Radiopharmaceutical Non-clinical CRO Service Industry Trends
2.3.2 Radiopharmaceutical Non-clinical CRO Service Market Drivers
2.3.3 Radiopharmaceutical Non-clinical CRO Service Market Challenges
2.3.4 Radiopharmaceutical Non-clinical CRO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Revenue
3.1.1 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Revenue (2020-2025)
3.1.2 Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Radiopharmaceutical Non-clinical CRO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiopharmaceutical Non-clinical CRO Service Revenue
3.4 Global Radiopharmaceutical Non-clinical CRO Service Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Non-clinical CRO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Non-clinical CRO Service Revenue in 2024
3.5 Global Key Players of Radiopharmaceutical Non-clinical CRO Service Head office and Area Served
3.6 Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Product and Application
3.7 Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Non-clinical CRO Service Breakdown Data by Type
4.1 Global Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Type (2020-2025)
4.2 Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Type (2026-2031)
5 Radiopharmaceutical Non-clinical CRO Service Breakdown Data by Application
5.1 Global Radiopharmaceutical Non-clinical CRO Service Historic Market Size by Application (2020-2025)
5.2 Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
6.2 North America Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
6.4 North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
7.2 Europe Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
7.4 Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
8.2 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
9.2 Latin America Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
9.4 Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size (2020-2031)
10.2 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiopharmaceutical Non-clinical CRO Service Introduction
11.1.4 Charles River Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Novotech
11.2.1 Novotech Company Details
11.2.2 Novotech Business Overview
11.2.3 Novotech Radiopharmaceutical Non-clinical CRO Service Introduction
11.2.4 Novotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.2.5 Novotech Recent Development
11.3 Oncodesign Services
11.3.1 Oncodesign Services Company Details
11.3.2 Oncodesign Services Business Overview
11.3.3 Oncodesign Services Radiopharmaceutical Non-clinical CRO Service Introduction
11.3.4 Oncodesign Services Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.3.5 Oncodesign Services Recent Development
11.4 Aixial
11.4.1 Aixial Company Details
11.4.2 Aixial Business Overview
11.4.3 Aixial Radiopharmaceutical Non-clinical CRO Service Introduction
11.4.4 Aixial Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.4.5 Aixial Recent Development
11.5 ABX - CRO
11.5.1 ABX - CRO Company Details
11.5.2 ABX - CRO Business Overview
11.5.3 ABX - CRO Radiopharmaceutical Non-clinical CRO Service Introduction
11.5.4 ABX - CRO Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.5.5 ABX - CRO Recent Development
11.6 CMIC
11.6.1 CMIC Company Details
11.6.2 CMIC Business Overview
11.6.3 CMIC Radiopharmaceutical Non-clinical CRO Service Introduction
11.6.4 CMIC Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.6.5 CMIC Recent Development
11.7 Medpace
11.7.1 Medpace Company Details
11.7.2 Medpace Business Overview
11.7.3 Medpace Radiopharmaceutical Non-clinical CRO Service Introduction
11.7.4 Medpace Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.7.5 Medpace Recent Development
11.8 Minerva Imaging
11.8.1 Minerva Imaging Company Details
11.8.2 Minerva Imaging Business Overview
11.8.3 Minerva Imaging Radiopharmaceutical Non-clinical CRO Service Introduction
11.8.4 Minerva Imaging Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.8.5 Minerva Imaging Recent Development
11.9 Chelatec
11.9.1 Chelatec Company Details
11.9.2 Chelatec Business Overview
11.9.3 Chelatec Radiopharmaceutical Non-clinical CRO Service Introduction
11.9.4 Chelatec Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.9.5 Chelatec Recent Development
11.10 Konica Minolta
11.10.1 Konica Minolta Company Details
11.10.2 Konica Minolta Business Overview
11.10.3 Konica Minolta Radiopharmaceutical Non-clinical CRO Service Introduction
11.10.4 Konica Minolta Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.10.5 Konica Minolta Recent Development
11.11 MITRO Biotech
11.11.1 MITRO Biotech Company Details
11.11.2 MITRO Biotech Business Overview
11.11.3 MITRO Biotech Radiopharmaceutical Non-clinical CRO Service Introduction
11.11.4 MITRO Biotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.11.5 MITRO Biotech Recent Development
11.12 C-Ray
11.12.1 C-Ray Company Details
11.12.2 C-Ray Business Overview
11.12.3 C-Ray Radiopharmaceutical Non-clinical CRO Service Introduction
11.12.4 C-Ray Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.12.5 C-Ray Recent Development
11.13 InnoStar Bio-tech
11.13.1 InnoStar Bio-tech Company Details
11.13.2 InnoStar Bio-tech Business Overview
11.13.3 InnoStar Bio-tech Radiopharmaceutical Non-clinical CRO Service Introduction
11.13.4 InnoStar Bio-tech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
11.13.5 InnoStar Bio-tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tracers
Table 3. Key Players of Therapeutic Radiopharmaceuticals
Table 4. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Tumor Diseases
Table 6. Key Players of Nervous System Diseases
Table 7. Key Players of Cardiovascular Diseases
Table 8. Key Players of Other
Table 9. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2020-2025)
Table 13. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2026-2031)
Table 15. Radiopharmaceutical Non-clinical CRO Service Market Trends
Table 16. Radiopharmaceutical Non-clinical CRO Service Market Drivers
Table 17. Radiopharmaceutical Non-clinical CRO Service Market Challenges
Table 18. Radiopharmaceutical Non-clinical CRO Service Market Restraints
Table 19. Global Radiopharmaceutical Non-clinical CRO Service Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Players (2020-2025)
Table 21. Global Top Radiopharmaceutical Non-clinical CRO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Non-clinical CRO Service as of 2024)
Table 22. Ranking of Global Top Radiopharmaceutical Non-clinical CRO Service Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Radiopharmaceutical Non-clinical CRO Service Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Headquarters and Area Served
Table 25. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Product and Application
Table 26. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Type (2026-2031)
Table 32. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Application (2020-2025)
Table 34. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Application (2026-2031)
Table 36. North America Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 51. Charles River Company Details
Table 52. Charles River Business Overview
Table 53. Charles River Radiopharmaceutical Non-clinical CRO Service Product
Table 54. Charles River Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 55. Charles River Recent Development
Table 56. Novotech Company Details
Table 57. Novotech Business Overview
Table 58. Novotech Radiopharmaceutical Non-clinical CRO Service Product
Table 59. Novotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 60. Novotech Recent Development
Table 61. Oncodesign Services Company Details
Table 62. Oncodesign Services Business Overview
Table 63. Oncodesign Services Radiopharmaceutical Non-clinical CRO Service Product
Table 64. Oncodesign Services Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 65. Oncodesign Services Recent Development
Table 66. Aixial Company Details
Table 67. Aixial Business Overview
Table 68. Aixial Radiopharmaceutical Non-clinical CRO Service Product
Table 69. Aixial Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 70. Aixial Recent Development
Table 71. ABX - CRO Company Details
Table 72. ABX - CRO Business Overview
Table 73. ABX - CRO Radiopharmaceutical Non-clinical CRO Service Product
Table 74. ABX - CRO Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 75. ABX - CRO Recent Development
Table 76. CMIC Company Details
Table 77. CMIC Business Overview
Table 78. CMIC Radiopharmaceutical Non-clinical CRO Service Product
Table 79. CMIC Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 80. CMIC Recent Development
Table 81. Medpace Company Details
Table 82. Medpace Business Overview
Table 83. Medpace Radiopharmaceutical Non-clinical CRO Service Product
Table 84. Medpace Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 85. Medpace Recent Development
Table 86. Minerva Imaging Company Details
Table 87. Minerva Imaging Business Overview
Table 88. Minerva Imaging Radiopharmaceutical Non-clinical CRO Service Product
Table 89. Minerva Imaging Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 90. Minerva Imaging Recent Development
Table 91. Chelatec Company Details
Table 92. Chelatec Business Overview
Table 93. Chelatec Radiopharmaceutical Non-clinical CRO Service Product
Table 94. Chelatec Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 95. Chelatec Recent Development
Table 96. Konica Minolta Company Details
Table 97. Konica Minolta Business Overview
Table 98. Konica Minolta Radiopharmaceutical Non-clinical CRO Service Product
Table 99. Konica Minolta Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 100. Konica Minolta Recent Development
Table 101. MITRO Biotech Company Details
Table 102. MITRO Biotech Business Overview
Table 103. MITRO Biotech Radiopharmaceutical Non-clinical CRO Service Product
Table 104. MITRO Biotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 105. MITRO Biotech Recent Development
Table 106. C-Ray Company Details
Table 107. C-Ray Business Overview
Table 108. C-Ray Radiopharmaceutical Non-clinical CRO Service Product
Table 109. C-Ray Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 110. C-Ray Recent Development
Table 111. InnoStar Bio-tech Company Details
Table 112. InnoStar Bio-tech Business Overview
Table 113. InnoStar Bio-tech Radiopharmaceutical Non-clinical CRO Service Product
Table 114. InnoStar Bio-tech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 115. InnoStar Bio-tech Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Radiopharmaceutical Non-clinical CRO Service Picture
Figure 2. Global Radiopharmaceutical Non-clinical CRO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Type: 2024 VS 2031
Figure 4. Tracers Features
Figure 5. Therapeutic Radiopharmaceuticals Features
Figure 6. Global Radiopharmaceutical Non-clinical CRO Service Market Size Comparison by Disease (2020-2031) & (US$ Million)
Figure 7. Tumor Diseases Features
Figure 8. Nervous System Diseases Features
Figure 9. Cardiovascular Diseases Features
Figure 10. Other Features
Figure 11. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Application: 2024 VS 2031
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Biotech Companies Case Studies
Figure 15. Government Agencies Case Studies
Figure 16. Other Case Studies
Figure 17. Radiopharmaceutical Non-clinical CRO Service Report Years Considered
Figure 18. Global Radiopharmaceutical Non-clinical CRO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Radiopharmaceutical Non-clinical CRO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region: 2024 VS 2031
Figure 21. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Players in 2024
Figure 22. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Radiopharmaceutical Non-clinical CRO Service Revenue in 2024
Figure 24. North America Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 26. United States Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 30. Germany Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2020-2031)
Figure 38. China Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 46. Mexico Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 50. Israel Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Charles River Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 54. Novotech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 55. Oncodesign Services Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 56. Aixial Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 57. ABX - CRO Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 58. CMIC Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 59. Medpace Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 60. Minerva Imaging Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 61. Chelatec Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 62. Konica Minolta Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 63. MITRO Biotech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 64. C-Ray Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 65. InnoStar Bio-tech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tracers
Table 3. Key Players of Therapeutic Radiopharmaceuticals
Table 4. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Tumor Diseases
Table 6. Key Players of Nervous System Diseases
Table 7. Key Players of Cardiovascular Diseases
Table 8. Key Players of Other
Table 9. Global Radiopharmaceutical Non-clinical CRO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2020-2025)
Table 13. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2026-2031)
Table 15. Radiopharmaceutical Non-clinical CRO Service Market Trends
Table 16. Radiopharmaceutical Non-clinical CRO Service Market Drivers
Table 17. Radiopharmaceutical Non-clinical CRO Service Market Challenges
Table 18. Radiopharmaceutical Non-clinical CRO Service Market Restraints
Table 19. Global Radiopharmaceutical Non-clinical CRO Service Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Players (2020-2025)
Table 21. Global Top Radiopharmaceutical Non-clinical CRO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Non-clinical CRO Service as of 2024)
Table 22. Ranking of Global Top Radiopharmaceutical Non-clinical CRO Service Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Radiopharmaceutical Non-clinical CRO Service Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Headquarters and Area Served
Table 25. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Product and Application
Table 26. Global Key Players of Radiopharmaceutical Non-clinical CRO Service, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Type (2026-2031)
Table 32. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Application (2020-2025)
Table 34. Global Radiopharmaceutical Non-clinical CRO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Radiopharmaceutical Non-clinical CRO Service Revenue Market Share by Application (2026-2031)
Table 36. North America Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size by Country (2026-2031) & (US$ Million)
Table 51. Charles River Company Details
Table 52. Charles River Business Overview
Table 53. Charles River Radiopharmaceutical Non-clinical CRO Service Product
Table 54. Charles River Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 55. Charles River Recent Development
Table 56. Novotech Company Details
Table 57. Novotech Business Overview
Table 58. Novotech Radiopharmaceutical Non-clinical CRO Service Product
Table 59. Novotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 60. Novotech Recent Development
Table 61. Oncodesign Services Company Details
Table 62. Oncodesign Services Business Overview
Table 63. Oncodesign Services Radiopharmaceutical Non-clinical CRO Service Product
Table 64. Oncodesign Services Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 65. Oncodesign Services Recent Development
Table 66. Aixial Company Details
Table 67. Aixial Business Overview
Table 68. Aixial Radiopharmaceutical Non-clinical CRO Service Product
Table 69. Aixial Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 70. Aixial Recent Development
Table 71. ABX - CRO Company Details
Table 72. ABX - CRO Business Overview
Table 73. ABX - CRO Radiopharmaceutical Non-clinical CRO Service Product
Table 74. ABX - CRO Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 75. ABX - CRO Recent Development
Table 76. CMIC Company Details
Table 77. CMIC Business Overview
Table 78. CMIC Radiopharmaceutical Non-clinical CRO Service Product
Table 79. CMIC Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 80. CMIC Recent Development
Table 81. Medpace Company Details
Table 82. Medpace Business Overview
Table 83. Medpace Radiopharmaceutical Non-clinical CRO Service Product
Table 84. Medpace Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 85. Medpace Recent Development
Table 86. Minerva Imaging Company Details
Table 87. Minerva Imaging Business Overview
Table 88. Minerva Imaging Radiopharmaceutical Non-clinical CRO Service Product
Table 89. Minerva Imaging Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 90. Minerva Imaging Recent Development
Table 91. Chelatec Company Details
Table 92. Chelatec Business Overview
Table 93. Chelatec Radiopharmaceutical Non-clinical CRO Service Product
Table 94. Chelatec Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 95. Chelatec Recent Development
Table 96. Konica Minolta Company Details
Table 97. Konica Minolta Business Overview
Table 98. Konica Minolta Radiopharmaceutical Non-clinical CRO Service Product
Table 99. Konica Minolta Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 100. Konica Minolta Recent Development
Table 101. MITRO Biotech Company Details
Table 102. MITRO Biotech Business Overview
Table 103. MITRO Biotech Radiopharmaceutical Non-clinical CRO Service Product
Table 104. MITRO Biotech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 105. MITRO Biotech Recent Development
Table 106. C-Ray Company Details
Table 107. C-Ray Business Overview
Table 108. C-Ray Radiopharmaceutical Non-clinical CRO Service Product
Table 109. C-Ray Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 110. C-Ray Recent Development
Table 111. InnoStar Bio-tech Company Details
Table 112. InnoStar Bio-tech Business Overview
Table 113. InnoStar Bio-tech Radiopharmaceutical Non-clinical CRO Service Product
Table 114. InnoStar Bio-tech Revenue in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025) & (US$ Million)
Table 115. InnoStar Bio-tech Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Radiopharmaceutical Non-clinical CRO Service Picture
Figure 2. Global Radiopharmaceutical Non-clinical CRO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Type: 2024 VS 2031
Figure 4. Tracers Features
Figure 5. Therapeutic Radiopharmaceuticals Features
Figure 6. Global Radiopharmaceutical Non-clinical CRO Service Market Size Comparison by Disease (2020-2031) & (US$ Million)
Figure 7. Tumor Diseases Features
Figure 8. Nervous System Diseases Features
Figure 9. Cardiovascular Diseases Features
Figure 10. Other Features
Figure 11. Global Radiopharmaceutical Non-clinical CRO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Application: 2024 VS 2031
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Biotech Companies Case Studies
Figure 15. Government Agencies Case Studies
Figure 16. Other Case Studies
Figure 17. Radiopharmaceutical Non-clinical CRO Service Report Years Considered
Figure 18. Global Radiopharmaceutical Non-clinical CRO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Radiopharmaceutical Non-clinical CRO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Region: 2024 VS 2031
Figure 21. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Players in 2024
Figure 22. Global Radiopharmaceutical Non-clinical CRO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Radiopharmaceutical Non-clinical CRO Service Revenue in 2024
Figure 24. North America Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 26. United States Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 30. Germany Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Radiopharmaceutical Non-clinical CRO Service Market Share by Region (2020-2031)
Figure 38. China Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 46. Mexico Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Radiopharmaceutical Non-clinical CRO Service Market Share by Country (2020-2031)
Figure 50. Israel Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Radiopharmaceutical Non-clinical CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Charles River Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 54. Novotech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 55. Oncodesign Services Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 56. Aixial Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 57. ABX - CRO Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 58. CMIC Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 59. Medpace Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 60. Minerva Imaging Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 61. Chelatec Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 62. Konica Minolta Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 63. MITRO Biotech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 64. C-Ray Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 65. InnoStar Bio-tech Revenue Growth Rate in Radiopharmaceutical Non-clinical CRO Service Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232